Public safety technology firm Axon raises FY revenue outlook after Q3 beat

Reuters
2025/11/05
Public safety technology firm Axon raises FY revenue outlook after Q3 beat

Overview

  • Axon Q3 2025 revenue grows 31% yr/yr, beating analysts' expectations

  • Company raises full-year revenue outlook to $2.74 bln

  • Net loss of $2 mln reported, with non-GAAP net income of $98 mln

Outlook

  • Company raises full-year revenue outlook to approximately $2.74 bln, up from $2.65-$2.73 bln

  • Axon expects Q4 revenue between $750 mln and $755 mln, about 31% growth

  • Company anticipates Q4 Adjusted EBITDA of $178 mln to $182 mln, 24% margin

Result Drivers

  • SOFTWARE & SERVICES GROWTH - Revenue increased 41% due to premium software adoption and expanding user base

  • CONNECTED DEVICES DEMAND - Revenue rose 24% with strong demand for TASER 10 and Axon Body 4

  • ACQUISITIONS - Completed acquisitions of Prepared and Carbyne to enhance 911 call handling and dispatch workflows

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$710.64 mln

$703.50 mln (16 Analysts)

Q3 EPS

-$0.03

Q3 Net Income

-$2 mln

Q3 Adjusted EBITDA

$177 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 19 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the aerospace & defense peer group is "buy"

  • Wall Street's median 12-month price target for Axon Enterprise Inc is $877.50, about 17.5% above its November 3 closing price of $724.10

  • The stock recently traded at 94 times the next 12-month earnings vs. a P/E of 107 three months ago

Press Release: ID:nPn1NWkx9a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10